Suppr超能文献

腹膜透析感染并发症处理的争议点。

Controversies in the management of infective complications of peritoneal dialysis.

机构信息

Department of Renal Medicine, Derby Hospitals NHS Foundation Trust, Derby, UK. aghogho.odudu @ nhs.net

出版信息

Nephron Clin Pract. 2011;118(3):c301-8. doi: 10.1159/000322227. Epub 2011 Jan 14.

Abstract

Peritoneal dialysis is an effective form of renal replacement therapy. Despite improvements in connection technology, peritoneal infection is still the most important preventable cause of patient morbidity and mortality. There has been a shift in focus from treatment to prevention of infection, but wide variation in peritonitis incidence across and within peritoneal dialysis populations remains. This minireview aims to highlight current best practice, whilst discussing controversies in the diagnosis, prediction, prevention and management of peritonitis. Exit-site infection will not be discussed per se but only as it relates to peritonitis.

摘要

腹膜透析是一种有效的肾脏替代治疗形式。尽管连接技术有所改进,但腹膜感染仍然是导致患者发病率和死亡率的最重要的可预防原因。人们的关注重点已经从治疗转移到预防感染,但腹膜透析人群的腹膜炎发病率在全球范围内和人群内部仍然存在很大差异。本篇迷你综述旨在强调当前的最佳实践,同时讨论腹膜炎的诊断、预测、预防和管理方面的争议。本文将不单独讨论出口部位感染,而是仅讨论其与腹膜炎的关系。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验